SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,598.00    12.00 (0.26%)
Bid:
4,596.00
Ask:
4,600.00
Spread: 4.00 (0.087%)
Market Cap: £16.76b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

CCH - Board Committees Composition

17 May 2023 15:44

RNS Number : 7744Z
Coca-Cola HBC AG
17 May 2023
 

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca-Cola HBC AG

 

 

Zug, Switzerland - 17 May 2023 - Coca-Cola HBC AG ("Coca-Cola HBC" or the "Company") announces today that following the election of the board members at the AGM the composition of the Board Committees will be as follows:

 

Audit and Risk Committee

William W. (Bill) Douglas (Chair) 

 

Olusola (Sola) David-Borha 

 

Alexandra Papalexopoulou

Nomination Committee

Reto Francioni (Chair)

 

Charlotte J. Boyle 

 

Anna Diamantopoulou

Remuneration Committee

Charlotte J. Boyle (Chair) 

 

Reto Francioni

 

Anna Diamantopoulou

Social Responsibility Committee 

Anastasios I. Leventis (Chair)

 

Anna Diamantopoulou

 

Evguenia (Jeny) Stoitchkova

 

This announcement is made pursuant to the Financial Conduct Authority's Listing Rule 9.6.11R and there are no other matters that require disclosure under Listing Rule 9.6.13R.

 Coca‑Cola HBC Group

Investor and Analysts:

John Dawson 

Head of Investor Relations

Tel: +44 7522 619509

 john.dawson@cchellenic.com

 

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

 

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

 

Virginia Phillips

Investor Relations Manager

 

Tel: +44 (0) 7864 686582

virginia.phillips@cchellenic.com

 

 

Media:

 

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

 

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate, and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa Coffee, Valser, Römerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 33,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCARMITMTIBBTJ
Date   Source Headline
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSNotice of EGM
24th Nov 20252:15 pmRNSDirector/PDMR Shareholding
18th Nov 20254:10 pmRNSDirector/PDMR Shareholding
5th Nov 20251:45 pmRNSDirector/PDMR Shareholding
3rd Nov 20259:30 amRNSBlock listing Interim Review
30th Oct 20253:00 pmRNSHolding(s) in Company
23rd Oct 20252:10 pmRNSDirector/PDMR Shareholding
23rd Oct 20252:00 pmRNSDirector/PDMR Shareholding
21st Oct 20257:03 amRNSSolid Q3 performance; guidance reiterated
21st Oct 20257:00 amRNSCCH to acquire Coca-Cola Beverages Africa
20th Oct 20253:45 pmRNSDirector/PDMR Shareholding
30th Sep 202511:30 amRNSNotice of Results
18th Sep 20252:30 pmRNSDirector/PDMR Shareholding
19th Aug 202512:00 pmRNSDirector/PDMR Shareholding
6th Aug 20257:00 amRNSConsistent execution delivers strong H1 results
4th Aug 20254:45 pmRNSRevolving Credit Facility
18th Jul 202512:15 pmRNSDirector/PDMR Shareholding
15th Jul 20251:00 pmRNSBitesize Investor Series – Nigeria
7th Jul 20251:09 pmRNSNotice of Results
3rd Jul 202510:04 amRNSHolding(s) in Company
2nd Jul 20253:29 pmRNSHolding(s) in Company
30th Jun 20253:32 pmRNSDirector/PDMR Shareholding
30th Jun 20251:44 pmRNSHolding(s) in Company
18th Jun 20252:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20251:19 pmRNSDirector/PDMR Shareholding
2nd Jun 20258:07 amRNSTransfer of treasury shares & total voting rights
23rd May 20252:05 pmRNSComposition of the Board Committees
23rd May 20251:55 pmRNSResult of AGM and dividend dates
20th May 20252:37 pmRNSDirector/PDMR Shareholding
19th May 202512:22 pmRNSDirector/PDMR Shareholding
7th May 20252:33 pmRNSDirector/PDMR Shareholding
1st May 20259:37 amRNSBlock listing Interim Review
1st May 20259:23 amRNSTransfer of treasury shares & total voting rights
30th Apr 20257:00 amRNSStrong start; reiterating 2025 guidance
23rd Apr 20251:38 pmRNSAGM Notice,changes to BoD,dividend dates-Amendment
23rd Apr 20257:00 amRNSNotice of AGM, changes to the BoD, dividend dates
22nd Apr 202512:42 pmRNSDirector/PDMR Shareholding
2nd Apr 202510:13 amRNSNotice of Results
1st Apr 20259:23 amRNSTransfer of treasury shares & total voting rights
28th Mar 20252:43 pmRNSDirector/PDMR Shareholding
28th Mar 20252:42 pmRNSDirector/PDMR Shareholding
28th Mar 20252:37 pmRNSDirector/PDMR Shareholding
19th Mar 20254:47 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20254:43 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20251:40 pmRNSDirector/PDMR Shareholding
19th Mar 20251:33 pmRNSDirector/PDMR Shareholding
19th Mar 20251:30 pmRNSDirector/PDMR Shareholding
19th Mar 20251:25 pmRNSDirector/PDMR Shareholding
19th Mar 20251:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.